Baxter names Andrew Hider as new CEO, effective September

DEERFIELD, Ill. - Baxter International Inc. (NYSE:BAX) announced Monday the appointment of Andrew Hider as its new president and chief executive officer, effective no later than September 3, 2025. Hider will also join Baxter’s board of directors, according to a company press release.

Hider will succeed Brent Shafer, who has served as chair and interim CEO since February 2025. Upon Hider’s arrival, Shafer will transition to the role of independent chair of Baxter’s board.

Hider currently serves as CEO of ATS Corporation (TSX and NYSE:ATS), a provider of automation solutions for various industries including life sciences. During his tenure at ATS since 2017, the company has shown strong growth, with InvestingPro data showing a 12% revenue CAGR over five years. The company’s market capitalization currently stands at $3.2 billion, though recent performance shows some volatility with revenue declining 16.5% in the last twelve months.

Prior to ATS, Hider was president and CEO of Taylor Made Group, LLC, and previously spent 10 years at Danaher Corporation in various leadership positions. He began his career with General Electric Co. in 2000. Hider also serves on the board of Tennant Company.

"Andrew is an exceptional leader with a strong track record of operational excellence, disciplined execution and innovation," said Shafer in the statement. According to InvestingPro analysis, ATS maintains strong financial health with a current ratio of 1.69, indicating solid liquidity management. The company’s stock has demonstrated resilience with a 12% return over the past six months, though analysts have recently revised earnings expectations downward. For deeper insights into ATS’s performance metrics and future outlook, investors can access the comprehensive Pro Research Report, available exclusively on InvestingPro.

Hider holds a bachelor’s degree in interdisciplinary engineering and management and an MBA from Clarkson University.

Baxter International, a global medical technology company, employs approximately 38,000 people worldwide and provides medical devices and injectable technologies across various healthcare settings.

In other recent news, ATS Corporation announced that its Chief Executive Officer, Andrew Hider, will step down from his position and the Board of Directors by the end of August. Ryan McLeod, the current Chief Financial Officer, will take on the role of interim CEO while the company searches for a permanent replacement. McLeod has been with ATS since 2020 and brings nearly two decades of experience to his interim leadership role. The company has also stated that its outlook for the current fiscal quarter and fiscal year remains unchanged despite the leadership transition. Additionally, Mike Martino, a current board member, is expected to become the new Board Chair following the company’s Annual General Meeting in August. The Board expressed gratitude for Hider’s contributions, noting his role in the company’s substantial growth. ATS plans to file an amendment to its management information circular to reflect Hider’s departure.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.